Document Detail

An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran).
MedLine Citation:
PMID:  19656552     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: The successful birth rate and adverse event profile indicates that danaparoid can be an effective and safe alternative anti-thrombotic in pregnancies complicated by HIT or intolerance or resistance to (LMW)heparins.
H N Magnani
Publication Detail:
Type:  Journal Article; Review     Date:  2009-08-05
Journal Detail:
Title:  Thrombosis research     Volume:  125     ISSN:  1879-2472     ISO Abbreviation:  Thromb. Res.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-26     Completed Date:  2010-07-02     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  297-302     Citation Subset:  IM    
Copyright Information:
(c) 2009 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Spontaneous / chemically induced,  drug therapy
Chondroitin Sulfates / administration & dosage*,  adverse effects,  therapeutic use*
Dermatan Sulfate / administration & dosage*,  adverse effects,  therapeutic use*
Exanthema / chemically induced,  drug therapy
Hemorrhage / chemically induced,  drug therapy
Heparin / adverse effects*,  therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Heparitin Sulfate* / administration & dosage,  adverse effects,  therapeutic use
Infant, Newborn
Infusions, Intravenous
Injections, Subcutaneous
Thrombosis / chemically induced,  drug therapy
Treatment Outcome
Reg. No./Substance:
0/Heparin, Low-Molecular-Weight; 24967-94-0/Dermatan Sulfate; 83513-48-8/danaproid; 9005-49-6/Heparin; 9007-28-7/Chondroitin Sulfates; 9050-30-0/Heparitin Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  No Article Title
Next Document:  The role of platelets CD40 ligand (CD154) in acute coronary syndromes.